137 related articles for article (PubMed ID: 29971186)
1. Retrospective analysis of mature cystic teratomas in a single center and review of the literature.
Yayla Abide Ç; Bostancı Ergen E
Turk J Obstet Gynecol; 2018 Jun; 15(2):95-98. PubMed ID: 29971186
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for malignant transformation of mature cystic teratoma.
Park CH; Jung MH; Ji YI
Obstet Gynecol Sci; 2015 Nov; 58(6):475-80. PubMed ID: 26623411
[TBL] [Abstract][Full Text] [Related]
3. Retrospective evaluation of tumor markers in ovarian mature cystic teratoma and ovarian endometrioma.
Kataoka T; Watanabe Y; Hoshiai H
J Obstet Gynaecol Res; 2012 Aug; 38(8):1071-6. PubMed ID: 22568880
[TBL] [Abstract][Full Text] [Related]
4. Mature cystic teratomas in our series with review of the literature and retrospective analysis.
Ozgur T; Atik E; Silfeler DB; Toprak S
Arch Gynecol Obstet; 2012 Apr; 285(4):1099-101. PubMed ID: 22167448
[TBL] [Abstract][Full Text] [Related]
5. Effects of mature cystic teratoma on reproductive health and malignant transformation: A retrospective analysis of 80 cases.
Kurt S; Avşar HA; Doğan ÖE; Saatli HB; Saygılı U
J Turk Ger Gynecol Assoc; 2019 May; 20(2):84-88. PubMed ID: 29755032
[TBL] [Abstract][Full Text] [Related]
6. Ovarian Mature Cystic Teratoma is an Independent Risk Factor for the Premature Rupture of Membranes in Pregnancy: A Single-Center Retrospective Study.
Sheng Y; Yuan J; Wang J; Wang L; Li Y; Wang Y
Int J Womens Health; 2022; 14():1477-1487. PubMed ID: 36277448
[TBL] [Abstract][Full Text] [Related]
7. Surgical treatment of mature cystic teratomas: A comparison of emergent and elective surgeries.
Ganer Herman H; Sagiv R; Raphaeli H; Kerner R; Keidar R; Bar J; Ginath S
J Obstet Gynaecol Res; 2017 Jan; 43(1):190-195. PubMed ID: 27935160
[TBL] [Abstract][Full Text] [Related]
8. Use of cancer antigen 125, cancer antigen 19-9, and the neutrophil-to-lymphocyte ratio to diagnose mature cystic teratoma with torsion.
Wang YQ; Xia WT; Wang F; Zhuang XX; Zheng FY; Lin F
Int J Gynaecol Obstet; 2017 Jun; 137(3):332-337. PubMed ID: 28273351
[TBL] [Abstract][Full Text] [Related]
9. The clinical significance of CA19-9 in ovarian mature cystic teratoma.
Fan JT; Yan HQ; Malla S; Fan YJ; Xu H; Li DH; Liu Y
Clin Exp Obstet Gynecol; 2016; 43(4):522-525. PubMed ID: 29734540
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological Evaluation of 223 Cases of Mature Cystic Teratoma, Ovary: 25-Year Experience in a Single Tertiary Care Centre in India.
Rathore R; Sharma S; Arora D
J Clin Diagn Res; 2017 Apr; 11(4):EC11-EC14. PubMed ID: 28571142
[TBL] [Abstract][Full Text] [Related]
11. CA19-9 elevation in ovarian mature cystic teratoma: discrimination from ovarian cancer - CA19-9 level in teratoma.
Cho HY; Kim K; Jeon YT; Kim YB; No JH
Med Sci Monit; 2013 Mar; 19():230-5. PubMed ID: 23539074
[TBL] [Abstract][Full Text] [Related]
12. Mature cystic teratomas: relationship between histopathological contents and clinical features.
Cakmak B; Nacar M; Ozsoy Z; Aliyev N; Koseoglu D
Niger J Clin Pract; 2015; 18(2):236-9. PubMed ID: 25665999
[TBL] [Abstract][Full Text] [Related]
13. Tumor markers in mature cystic teratomas of the ovary.
Ustunyurt E; Gungor T; Iskender C; Ustunyurt BO; Bilge U; Mollamahmutoglu L
Arch Gynecol Obstet; 2009 Feb; 279(2):145-7. PubMed ID: 18506458
[TBL] [Abstract][Full Text] [Related]
14. Is There a Role of Elevated CA 19-9 Levels in the Evaluation of Clinical Characteristics of Mature Cystic Ovarian Teratomas? A Systematic Review and Meta-analysis.
Prodromidou A; Pandraklakis A; Loutradis D; Haidopoulos D
Cureus; 2019 Dec; 11(12):e6342. PubMed ID: 31938630
[TBL] [Abstract][Full Text] [Related]
15. Elevated aspartate aminotransferase and alanine aminotransferase in the torsion of ovarian mature cystic teratoma: normalised after operation for torsion.
Namkung J; Park JH; Byun JH; Kim MR
J Obstet Gynaecol; 2021 May; 41(4):612-615. PubMed ID: 32811218
[TBL] [Abstract][Full Text] [Related]
16. CA 19-9 in evaluation of adnexal mass: retrospective cohort analysis and review of the literature.
Sagi-Dain L; Lavie O; Auslander R; Sagi S
Int J Biol Markers; 2015 Jul; 30(3):e333-40. PubMed ID: 25704505
[TBL] [Abstract][Full Text] [Related]
17. Role of elevated cancer antigen 19-9 in women with mature cystic teratoma.
Frimer M; Seagle BL; Chudnoff S; Goldberg GL; Shahabi S
Reprod Sci; 2014 Oct; 21(10):1307-11. PubMed ID: 24577158
[TBL] [Abstract][Full Text] [Related]
18. Age-stratified analysis of tumor markers and tumor characteristics in adolescents and young women with mature cystic teratoma.
Yesilyurt H; Seckin B; Aktulay A; Ozyer S
J Chin Med Assoc; 2018 Jun; 81(6):499-504. PubMed ID: 28826726
[TBL] [Abstract][Full Text] [Related]
19. Do high levels of CA 19-9 in women with mature cystic teratomas of the ovary warrant further evaluation?
Ugur MG; Ozturk E; Balat O; Dikensoy E; Teke S; Aydin A
Eur J Gynaecol Oncol; 2012; 33(2):207-10. PubMed ID: 22611965
[TBL] [Abstract][Full Text] [Related]
20. Mature cystic teratoma of the fallopian tube in a postmenopausal woman: a case report and review of the literature.
Sari ME; Ozdemir O; Kadirogullari P; Ertugrul FA; Atalay CR
Case Rep Obstet Gynecol; 2015; 2015():583021. PubMed ID: 25667777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
